A. Dosanjh et al., ELEVATED SERUM EOSINOPHIL CATIONIC PROTEIN-LEVELS IN CYSTIC-FIBROSIS,PEDIATRIC ASTHMA, AND BRONCHIOLITIS, Pediatric asthma, allergy & immunology, 10(4), 1996, pp. 169-173
Serum levels of eosinophil cationic protein (ECP) may correlate with a
ctivity in certain disease states, suggesting that eosinophils and the
ir toxic granular products are involved in the pathogenesis of the dis
ease, The aim of this study was to measure the serum concentration of
ECP in patients with cystic fibrosis (CF), pediatric asthma, and viral
bronchiolitis. The absolute number of blood eosinophils and IgE level
s were determined simultaneously. Serum ECP levels were the highest in
CF patients (median, 3101 mu g/L, +/- 463, N = 18), followed by those
with asthma (median, 1113 mu g/L, +/- 795, N = 10) and those with vir
al bronchiolitis (median, 1281 mu g/L, +/- 274, N = 9), Control patien
ts with no infection or lung disease all had ECP levels between 2 and
58 mu g/L (median, 3.7 +/- 14.7 mu g/L, N = 10). The CF patients studi
ed had a significantly higher level of ECP when compared to pediatric
asthma and viral bronchiolitis patients (p = 0.008), There was no corr
elation between the IgE level or absolute eosinophil count and the ECP
level, Among the CF patients studied, the forced expiratory volume in
1 second (FEV(1)) and ECP level did show a significant inverse correl
ation, (p < 0.01, probability). The finding of elevated ECP levels in
CF patients indicates the presence of eosinophil activation in these p
atients, The correlation between ECP and airflow obstruction suggests
a role for activated eosinophils in disease pathogenesis.